ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,224Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 19

$470K Total Retail Price of All Prescriptions

Rank: 2 out of 19

510 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 9,526 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
OMEPRAZOLE 472 430 1 4
LEVOTHYROXINE SODIUM 419 384 2 2
SIMVASTATIN 391 387 3 6
LISINOPRIL 356 340 4 3
FUROSEMIDE 329 305 5 8
POTASSIUM CHLORIDE 287 275 6 9
METFORMIN HCL 243 225 7 5
METOPROLOL SUCCINATE 217 217 8 18
SULINDAC 212 210 9 56
AMLODIPINE BESYLATE 177 167 10 7
INDOMETHACIN 172 161 R 10 11 64
ATORVASTATIN CALCIUM 164 146 12 17
CEFADROXIL 154 145 13 67
METOPROLOL TARTRATE 143 133 14 12
TAMSULOSIN HCL 133 129 15 27
WARFARIN SODIUM 130 130 16 13
PANTOPRAZOLE SODIUM 130 121 16 49
TRAMADOL HCL 129 129 18 22
NEXIUM 127 99 19 32
RANITIDINE HCL 127 76 19 19
DONEPEZIL HCL 120 120 21 38
SPIRONOLACTONE 116 112 22 41
VENLAFAXINE HCL ER 113 112 23 76
IBUPROFEN 113 98 23 26
ATENOLOL 112 106 25 15
HYDROCHLOROTHIAZIDE 106 96 26 10
PAROXETINE HCL 101 96 27 51
DICYCLOMINE HCL 93 59 28 85
GABAPENTIN 92 82 29 11
LACTULOSE 89 86 30 68
GLIPIZIDE 87 87 31 31
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 79 32 14
CILOSTAZOL 80 80 33 88
CLOPIDOGREL 76 76 34 42
HYDROCODONE-ACETAMINOPHEN 74 74 S3 35 1
VESICARE 71 71 36 93
PERPHENAZINE-AMITRIPTYLINE 71 71 R 36 93
CARBIDOPA-LEVODOPA 68 68 38 95
FLUTICASONE PROPIONATE 67 64 39 96
ADVAIR DISKUS 66 64 40 73
ALLOPURINOL 62 62 41 24
CELEBREX 62 62 41 99
DIOVAN HCT 61 53 43 101
RISPERIDONE 61 60 43 53
VYTORIN 60 60 45 104
FLUOXETINE HCL 60 54 45 46
CARVEDILOL 60 60 45 29
PLAVIX 59 59 48 52
CITALOPRAM HBR 58 53 49 36
SULFAMETHOXAZOLE-TRIMETHOPRIM 56 55 50 113
NABUMETONE 55 55 51 115
CLONIDINE HCL 55 55 51 37
MIRTAZAPINE 53 39 53 119
LANTUS 51 32 54 28
QUINAPRIL HCL 50 50 55 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.